Acute myelogenous leukaemia following etanercept therapy

被引：27

作者：

Bakland, G

Nossent, H ^{[1
]}

机构：

[1] Univ Tromso Hosp, Dept Rheumatol, N-9038 Tromso, Norway

[2] Univ Tromso, Inst Clin Med, N-9001 Tromso, Norway

来源：

RHEUMATOLOGY | 2003年 / 42卷 / 07期

关键词：

Systemic lupus erythematosus; Antiphospholipid syndrome; Atherosclerosis; Anti-HDL; Anti-Apo A-I; Cross-reactivity;

D O I：

10.1093/rheumatology/keg128

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：900 / 901

页数：2

共 11 条

[1] Risk of haematological malignancies in HLA-B27 carriers [J].

Au, WY ;

Hawkins, BR ;

Cheng, N ;

Lie, AKW ;

Liang, R ;

Kwong, YL .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (02) :320-322

[2]

Baghai M, 2001, MAYO CLIN PROC, V76, P653

[3] Safety and efficacy of disease-modifying anti-rheumatic agents - Focus on the benefits and risks of etanercept [J].

Fleischmann, R ;

Iqbal, I ;

Nandeshwar, P ;

Quiceno, A .

DRUG SAFETY, 2002, 25 (03) :173-197

[4] Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy [J].

Iyer, S ;

Yamauchi, P ;

Lowe, NJ .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (01) :118-121

[5] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[6] Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial [J].

Moreland, LW ;

Schiff, MH ;

Baumgartner, SW ;

Tindall, EA ;

Fleischmann, RM ;

Bulpitt, KJ ;

Weaver, AL ;

Keystone, EC ;

Furst, DE ;

Mease, PJ ;

Ruderman, EM ;

Horwitz, DA ;

Arkfeld, DG ;

Garrison, L ;

Burge, DJ ;

Blosch, CM ;

Lange, MLM ;

McDonnell, ND ;

Weinblatt, ME .

ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :478-+

[7] Adaptive basis function for artificial neural networks [J].

Philip, NS ;

Joseph, KB .

NEUROCOMPUTING, 2002, 47 :21-34

[8]

Stone JH, 2001, ARTHRITIS RHEUM, V44, P1149, DOI 10.1002/1529-0131(200105)44:5<1149::AID-ANR197>3.0.CO

[9]

2-F

[10] A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate [J].

Weinblatt, ME ;

Kremer, JM ;

Bankhurst, AD ;

Bulpitt, KJ ;

Fleischmann, RM ;

Fox, RI ;

Jackson, CG ;

Lange, M ;

Burge, DJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :253-259

← 1 2 →